OTTplay Logo
settings icon
profile icon

Yeh Kaali Kaali Ankhein Behind the Scenes: Tahir Raj Bhasin explains how the series gets darker and murkier

Director Siddharth Sengupta explains his idea to explore the darker side of a nice guy in Yeh Kaali Kaali Ankhein.

Yeh Kaali Kaali Ankhein Behind the Scenes: Tahir Raj Bhasin explains how the series gets darker and murkier

Last Updated: 12.37 PM, Jan 28, 2022

Share

After the success of Yeh Kaali Kaali Ankhein, the makers have released multiple fun videos from the hit series including the fun interaction with the cast, the peppy title track dance challenge and more. Netflix has now unveiled the BTS video from the crime-drama series. 

The latest video begins with the famous lines by Tahir Raj Bhasin's character, where he says, "There are three things that can ruin a man's life. Money. Power. And a woman. 

Shweta Tripathi Sharma can be seen talking in front of the camera, where she reveals her point of view about the series. The actress says, "Yeh Kaali Kaali Ankhein is full drama, it's full of blasts, it's full of love." "It's a beautiful, chaotic love story. It's pulp. It's a lot of masala and drama," explains Anchal Singh.

Check out the latest video here:

image_item

The lead actor also shares his opinion about the show and says, "Starts off as a very simple, basic story. But then as the episodes progress, it just gets darker and murkier."

Adding to the same, director Siddharth Sengupta explains his vision about his directorial and mentions, "We are all, in one way or the other, very dark on the inside. We are selfish. That is the idea, to explore the darker side of a nice guy."

Furthermore, Tahir adds that he can relate to the romanticism of his character Vikrant and the fact that he's is a die-hard romantic. 

The main cast and crew of Yeh Kaali Kaali Ankhein share some more facts and info about the series, while the BTS video shows how the shoot has been done.

Yeh Kaali Kaali Ankhein also features Surya Sharma, Arunoday Singh, Saurabh Shukla as the antagonists.

      Get the latest updates in your inbox
      Subscribe